JPY 849.0
(0.24%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 175.2 Million | -541.93 Million | 999.95 Million | 1.09 Billion | 1.34 Billion | 599.26 Million |
Net Income | 212.48 Million | 583.88 Million | 1.41 Billion | 1.31 Billion | 944.48 Million | 1.28 Billion |
Depreciation & Amortization | 422.06 Million | 390.82 Million | 282.42 Million | 315.05 Million | 504.08 Million | 587.8 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | -559.46 Million | -1.09 Billion | -281.42 Million | -295.7 Million | 297.43 Million | -297.13 Million |
Other non-cash items | 1.53 Billion | -420.89 Million | -415.96 Million | -236.18 Million | -405.81 Million | -979.3 Million |
Investing Cash Flow | -593.19 Million | -168.93 Million | -290.17 Million | -273.8 Million | -188.5 Million | -282.97 Million |
Investments in PPE | -442.26 Million | -387.09 Million | -280.62 Million | -287.62 Million | -417.82 Million | -461.24 Million |
Acquisitions | 2.43 Million | 22.75 Million | 20.03 Million | 13.44 Million | -15.22 Million | 603.78 Million |
Investment purchases | -788.34 Million | -714.77 Million | -831.61 Million | -1.57 Billion | -3.12 Billion | -2.67 Billion |
Sales/Maturities of investments | 698.79 Million | 930.13 Million | 823.95 Million | 1.55 Billion | 3.41 Billion | 2.25 Billion |
Other Investing Activities | -63.81 Million | -19.96 Million | -21.92 Million | 19.8 Million | -41.11 Million | -6.45 Million |
Financing Cash Flow | -227.27 Million | -187.39 Million | -241.72 Million | -272.53 Million | -297.95 Million | -867.62 Million |
Debt repayment | -14.3 Million | -320 Million | -530 Million | -460 Million | -430 Million | -779.81 Million |
Dividends payments | -211.62 Million | -211.42 Million | -246.95 Million | -155.56 Million | -155.08 Million | -161.89 Million |
Common Stock Repurchased | -55 Thousand | -9000.00 | -31 Thousand | -51 Thousand | -66 Thousand | -606.15 Million |
Common Stock Issuance | - | 344.03 Million | 530.26 Million | 343.07 Million | 429.2 Million | 680.24 Million |
Other Financing Activities | -2000.00 | -1000.00 | 5 Million | -1000.00 | -142 Million | -1000.00 |
Accounts receivables | 165.29 Million | -297 Million | -95 Million | -64 Million | 204 Million | 284 Million |
Accounts payables | -682.62 Million | -106.35 Million | 86.42 Million | -539.29 Million | 227.26 Million | 66.53 Million |
Inventory | -70.8 Million | -741.99 Million | -73.7 Million | 353.28 Million | -398.23 Million | -529.94 Million |
Other working capital | 28.66 Million | 49.6 Million | -199.14 Million | -45.69 Million | 264.4 Million | -117.73 Million |
Cash at beginning of period | 9.72 Billion | 10.49 Billion | 9.82 Billion | 9.26 Billion | 8.42 Billion | 9.04 Billion |
Cash at end of period | 9.2 Billion | 9.72 Billion | 10.49 Billion | 9.82 Billion | 9.26 Billion | 8.42 Billion |
Capital Expenditure | -442.26 Million | -387.09 Million | -280.62 Million | -287.62 Million | -417.82 Million | -461.24 Million |
Effect of forex changes on cash | 124.36 Million | 128.41 Million | 199.81 Million | 7.55 Million | -9.98 Million | -70.63 Million |
Net cash flow / Change in cash | -520.89 Million | -769.85 Million | 667.86 Million | 557.87 Million | 843.74 Million | -621.96 Million |
Free Cash Flow | -267.06 Million | -929.02 Million | 719.33 Million | 809.03 Million | 922.36 Million | 138.02 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 19 Million | -172 Million | 212.48 Million | 438 Million | -29 Million | -25 Million |
Depreciation & Amortization | - | - | 422.06 Million | 109.34 Million | 97.76 Million | 83.18 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | -559.46 Million | - | - | - |
Other non-cash items | -19 Million | 172 Million | 1.53 Billion | -438 Million | 29 Million | 25 Million |
Investing Cash Flow | - | - | -593.19 Million | - | - | - |
Investments in PPE | - | - | -442.26 Million | - | - | - |
Acquisitions | - | - | 2.43 Million | - | - | - |
Investment purchases | - | - | -788.34 Million | - | - | - |
Sales/Maturities of investments | - | - | 698.79 Million | - | - | - |
Other Investing Activities | - | - | -63.81 Million | - | - | - |
Financing Cash Flow | - | - | -227.27 Million | - | - | - |
Debt repayment | - | - | -14.3 Million | - | - | - |
Dividends payments | - | - | -211.62 Million | - | - | - |
Common Stock Repurchased | - | - | -55 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -2000.00 | - | - | - |
Accounts receivables | - | - | 165.29 Million | - | - | - |
Accounts payables | - | - | -682.62 Million | - | - | - |
Inventory | - | - | -70.8 Million | - | - | - |
Other working capital | - | - | 28.66 Million | - | - | - |
Cash at beginning of period | - | - | 9.72 Billion | 7.46 Billion | 9.4 Billion | 9.72 Billion |
Cash at end of period | - | - | 9.2 Billion | 8.48 Billion | 7.46 Billion | 9.4 Billion |
Capital Expenditure | - | - | -442.26 Million | - | - | - |
Effect of forex changes on cash | - | - | 124.36 Million | - | - | - |
Net cash flow / Change in cash | - | - | -520.89 Million | 1.02 Billion | -1.94 Billion | -312 Million |
Free Cash Flow | - | - | -267.06 Million | 218.69 Million | 195.52 Million | 166.37 Million |
002299
INCR
PVRINOX
SVM
NEULANDLAB
600760